Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation-Reference-Cited by-同舟云学术

Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation

Published:2020-07-13 Issue:3 Volume:87 Page:988-1000
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Souverein Patrick C.¹^ORCID,Ham Hendrika A.¹^ORCID,Huerta Consuelo²^ORCID,Merino Elisa Martín²,Montero Dolores²,León‐Muñoz Luz M.²,Schmiedl Sven³⁴,Heeke Andreas⁵,Rottenkolber Marietta⁶,Andersen Morten⁷^ORCID,Aakjaer Mia⁷,De Bruin Marie L.⁸^ORCID,Klungel Olaf H.¹,Gardarsdottir Helga¹^ORCID

Affiliation:

1. Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences Utrecht University The Netherlands

2. Pharmacoepidemiology and Pharmacovigilance Division Spanish Agency for Medicines and Medical Devices (AEMPS) Madrid Spain

3. Philipp Klee‐Institute for Clinical Pharmacology HELIOS Clinic Wuppertal Wuppertal Germany

4. Department of Clinical Pharmacology, School of Medicine, Faculty of Health Witten/Herdecke University Witten Germany

5. AOK NORDWEST Dortmund Germany

6. Diabetic Research Group, Medizinische Klinik und Poliklinik IV Klinikum der Universitaet Muenchen Munich Germany

7. Pharmacovigilance Research Group, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences University of Copenhagen Denmark

8. Copenhagen Centre of Regulatory Science, Department of Pharmacy University of Copenhagen Copenhagen Denmark

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14450

Reference39 articles.

1. Global Burden of Atrial Fibrillation in Developed and Developing Nations

2. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060

3. Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited

4. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

5. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Echocardiographic Hemodynamics Correlate with Differences in DOAC-specific Bleeding and Stroke Rates in Non-Valvular Atrial Fibrillation;2024-08-26

2. Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta‐Analysis;Journal of the American Heart Association;2024-08-20

3. Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort;Open Heart;2024-01

4. Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation With Low Stroke Risk;The American Journal of Cardiology;2023-10

5. Heterogeneity after harmonisation: A retrospective cohort study of bleeding and stroke risk after the introduction of direct oral anticoagulants in four Western European countries;Pharmacoepidemiology and Drug Safety;2023-06-21